Health tech form EQL has partnered with cashplan provider Medicash to launch Phio Engage, a self-care app for people needing musculoskeletal (MSK) treatment.
The launch into the health insurance market follows the success of Phio Access – a clinically-led digital triage support tool that signposts the most appropriate treatment for each MSK case.
Users have unlimited access to Phio Access, and then if they are identified as suitable for self-management, they will go through to Phio Engage to follow an exercise programme tailored to them.
Phio Engage enables people to control the intensity of the programme according to their needs, and tracks their progress, providing qualified clinical oversight and intervention through the app as required.
Commenting on the launch, Jason Ward, co-founder and CEO of EQL, said: “It’s great to be teaming up with Medicash, with its pedigree and track record in the sector, to launch Phio Engage into the healthcare market.
“We’re on a mission to improve and speed up access to healthcare, and to empower people to take control of their own healthcare needs. Phio is a great step forward in achieving that.
“It offers offers early intervention, consistent and transparent referral, empowered patients and better MSK management.”
Andy Roberts, finance and IT director for Medicash, added: “By promoting innovation, Medicash is helping to spur the digital transformation of healthcare,” he said.
“A digital MSK product has always been on our roadmap, and we feel that the Phio platform meets this need for policyholders. Our policyholders can start their Phio journey directly from the Medicash app, and the intuitive nature of the solution ensures there are no barriers to engagement.”
